HYTANBIO PT-141 Research Film
PT-141
Formula, active quantity, film dimensions, flavor and packaging are agreed after project review.
Proposed technical target from supplied table: 2 mg per film. Subject to analytical and feasibility validation.
Key ingredients
- PT-141
Ingredient identity and finished-unit control
Define the exact ingredient identity, source and proposed quantity before a thin-film trial. Evaluate compatibility, practical loading and the analytical method for the dried unit. Visual appearance cannot establish chemical content or a physiological effect.
Product direction
Laboratory formulation and analytical evaluation only. Identity, film recovery and stability must be assessed before any project specification is accepted.
Sampling, processing, packaging and storage are reviewed as one system. Confirm finished-unit uniformity and relevant stability before finalizing the commercial specification. Claims and ingredient eligibility require target-market assessment.
Project applications
Laboratory material evaluation, analytical method development and controlled formulation feasibility.
Customization
- Ingredient identity and quantity feasibility
- Film size, thickness and handling criteria
- Flavor and sensory evaluation
- Individual barrier sachet and carton design
- Finished-unit methods and stability plan
- Target-market documentation and label review
Product project specification
| Brand / code | HYTANBIO / R4 |
|---|---|
| Ingredient direction | PT-141 |
| Ingredient amount | 2 mg |
| Film thickness reference | Brochure average approximately 0.08 mm; project specification is confirmed separately |
| Packaging | Individual foil sachets; carton and pack count by project |
| MOQ / delivery | Quotation and written schedule after brief review |
Discuss R4 with our project team.
EMAIL: info@hytanbio.com